Patent Assignment
Reel/Frame 016547/0256
Assignment of Assignor's Interest
Recorded: 2005-05-10
Pages: 13
Assignor
ZENECA LIMITED (NOW SYNGENTA LIMITED)
Executed: 2004-05-20
Assignee
ASTRAZENECA UK LIMITED
15 STANHOPE GATE, LONDON, ENGLAND, W1K 1LN, UNITED KINGDOM
Covered Properties
(60)
Amide Derivatives
Patent:
4,636,505 →
Application:
06/514,332 →
Selective Oestrogen Therapy for Perimenopausal or Postmenopausal Conditions
Patent:
5,183,814 →
Application:
07/362,043 →
Process for Preparing (2R)-Methyl-4,4,4-Trifluorobutylamine
Patent:
5,274,118 →
Application:
07/803,291 →
Chemical Process for the Preparation of 3-Alkylated Indole
Patent:
5,280,125 →
Application:
07/803,315 →
Pharmaceutical Agents
Patent:
5,319,097 →
Application:
07/805,421 →
Crystalline Form of Indole Derivative and Phaarmaceutical Method Thereof
Patent:
5,294,636 →
Application:
07/805,426 →
Indolyl Tetrahydropyridines for Treating Migraine
Patent:
5,399,574 →
Application:
07/838,233 →
Pharmaceutical Agents
Patent:
5,352,694 →
Application:
07/940,138 →
Pharmaceutical Agents Useful as Leukotriene Antagonists
Patent:
5,482,963 →
Application:
08/116,781 →
Antibiotic Compounds
Patent:
5,478,820 →
Application:
08/129,056 →
Heterocyclic Derivatives
Patent:
5,455,253 →
Application:
08/227,833 →
Process for Preparing Physical Form of Parmaceutical Agent
Patent:
5,466,826 →
Application:
08/261,607 →
Quinazoline Derivatives Useful for Treatment of Neoplastic Disease
Patent:
5,457,105 →
Application:
08/284,293 →
Therapeutic Heterocycles Which Antagonize Neurokinin Receptors
Patent:
5,567,700 →
Application:
08/290,642 →
Angiotensin Ii Antagonists Against Disorders Associated with Impaired Neuronal Conduction Velocity, Especially Diabetic Neuropathy
Patent:
6,448,280 →
Application:
08/313,194 →
Therapeutic Heterocyclic Compounds
Patent:
5,466,699 →
Application:
08/341,206 →
Method for Preparing an Amorphous Sulfonamide
Patent:
5,504,216 →
Application:
08/403,132 →
Peptide Process
Patent:
5,510,460 →
Application:
08/451,980 →
Antibiotic Compounds
Patent:
5,652,233 →
Application:
08/462,037 →
Therapeutic Heterocyclic Compounds
Patent:
5,863,935 →
Application:
08/471,229 →
Salts of Peptides with Carboxy-Terminated Polyesters
Patent:
5,889,110 →
Application:
08/473,303 →
Method of Enhancing Bioavailability of Pharmaceutical Agents
Patent:
5,612,367 →
Application:
08/474,191 →
Quinazoline Derivatives as Anti-Proliferative Agents
Patent:
5,616,582 →
Application:
08/490,666 →
Heterocyclic Derivatives
Patent:
5,622,964 →
Application:
08/516,713 →
Syringes and Syringe Pumps
Patent:
5,882,338 →
Application:
08/545,706 →
Substituted Aralkyl Heterocyclic Compounds
Patent:
36,617 →
Application:
08/627,311 →
Pyridazion Quinoline Compounds
Patent:
5,744,471 →
Application:
08/637,641 →
Quinazoline Derivatives
Patent:
5,770,599 →
Application:
08/638,331 →
Heterocyclic Compounds
Patent:
5,866,568 →
Application:
08/658,969 →
Therapeutic Heterocycles
Patent:
5,861,392 →
Application:
08/689,199 →
Antibiotic Compounds
Patent:
5,856,321 →
Application:
08/833,056 →
Reservoirs and Delivery Devices
Patent:
5,980,501 →
Application:
08/860,381 →
Pharmaceutical Compositions Using Thiazepine
Patent:
5,948,437 →
Application:
08/864,306 →
One Pot Synthesis of 2-Oxazolidinone Derivatives
Patent:
6,084,103 →
Application:
09/011,045 →
4-Mercaptopyrrolidine Derivatives as Farnesyl Transferase Inhibitors
Patent:
6,232,338 →
Application:
09/011,135 →
Pyridazino Quinoline Compounds
Patent:
6,232,313 →
Application:
09/044,109 →
Therapeutic Heterocycles
Patent:
5,990,130 →
Application:
09/106,606 →
Pharmaceutical Agents
Patent:
5,993,859 →
Application:
09/114,225 →
Peptide Derivatives Useful in Treating Autoimmune Diseases
Patent:
6,087,336 →
Application:
09/125,517 →
Antibiotic Compounds
Patent:
6,187,804 →
Application:
09/168,293 →
Syringes and Syringe Pumps
Patent:
6,019,745 →
Application:
09/207,668 →
Heterocyclic Compounds
Patent:
6,060,475 →
Application:
09/211,483 →
Salts of Peptides with Carboxy-Terminated Polyesters
Patent:
6,034,175 →
Application:
09/235,270 →
Heterocycle Derivatives Which Inhibit Factor Xa
Patent:
6,300,330 →
Application:
09/297,768 →
Therapeutic Heterocycles
Patent:
6,124,279 →
Application:
09/336,087 →
Process for the Manufacture of Arylsulfonyl Chloride
Patent:
6,531,605 →
Application:
09/380,478 →
Process for Preparing Pharmaceutical Composition Containing a Heterocyclic Amide
Patent:
6,143,775 →
Application:
09/447,414 →
Heteroaryl-Substituted Pyridazino Quinoline Compounds
Patent:
6,103,721 →
Application:
09/455,096 →
Monocyte Chemoattractant Protein-1 Inhibitor Compounds
Patent:
6,441,004 →
Application:
09/485,061 →
One pot synthesis of 2-oxazolidinone derivatives
Patent:
6,160,123 →
Application:
09/496,409 →
A Substituted Pyrazin-2-Yl-Sulphonamide-(3-Pyridyl) Compounds and Uses Thereof
Patent:
6,258,817 →
Application:
09/504,364 →
Pharmaceutical Composition Containing Zafirlukast
Patent:
6,333,361 →
Application:
09/554,193 →
4-Mercaptopyrrolidine Derivatives as Farnesyl Transferase Inhibitors
Patent:
6,541,491 →
Application:
09/725,964 →
Antibiotic Compounds
Heterocyclic Derivatives
Crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
Application:
10/101,948 →
Publication:
US 2002/0147186
Antibiotic Compounds
Synthesis of Pyrazinyl Pyridine-3-Sulfonamide Compounds
Heterocycle Derivatives Which Inhibit Factor Xa
Application:
10/391,025 →
Nasal Spray
Patent:
433,124 →
Application:
29/090,469 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 2, 2003
From: ZENECA LIMITED (NOW SYNGENTA LIMITED)
To: ASTRAZENECA UK LIMITED
Reel/Frame 014235/0663 →
Change of Name
Jul 2, 2003
From: ZENECA LIMITED
To: SYNGENTA LIMITED
Reel/Frame 014235/0675 →
Change of Name
May 28, 2004
From: ZENECA LIMITED
To: SYNGENTA LIMITED
Reel/Frame 015355/0705 →
Change of Name
May 28, 2004
From: BURROUGHS WELLCOME CO.
To: GLAXO WELLCOME INC.
Reel/Frame 015394/0387 →